BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33291367)

  • 1. Effect of DODAB Nano-Sized Cationic Bilayer Fragments against
    Ferreira TCS; Sauter IP; Borda-Samper L; Bentivoglio E; DaMata JP; Taniwaki NN; Orrego PR; Araya JE; Lincopan N; Cortez M
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33291367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis.
    Stroppa PHF; Antinarelli LMR; Carmo AML; Gameiro J; Coimbra ES; da Silva AD
    Bioorg Med Chem; 2017 Jun; 25(12):3034-3045. PubMed ID: 28433512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-butyl-[1-(4-methoxy)phenyl-9H-β-carboline]-3-carboxamide prevents cytokinesis in Leishmania amazonensis.
    Stefanello TF; Panice MR; Ueda-Nakamura T; Sarragiotto MH; Auzély-Velty R; Nakamura CV
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7112-20. PubMed ID: 25224005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.
    Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S
    Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
    Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
    Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
    Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.
    Miguel DC; Yokoyama-Yasunaka JK; Andreoli WK; Mortara RA; Uliana SR
    J Antimicrob Chemother; 2007 Sep; 60(3):526-34. PubMed ID: 17584801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana
    Riezk A; Raynes JG; Yardley V; Murdan S; Croft SL
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of novel 4-aminoquinoline/1,2,3-triazole hybrids against Leishmania amazonensis.
    Glanzmann N; Antinarelli LMR; da Costa Nunes IK; Pereira HMG; Coelho EAF; Coimbra ES; da Silva AD
    Biomed Pharmacother; 2021 Sep; 141():111857. PubMed ID: 34323702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species.
    Mendonça DVC; Lage DP; Calixto SL; Ottoni FM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Schneider MS; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Parasitol Res; 2018 Feb; 117(2):391-403. PubMed ID: 29248978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Quinolinylhydrazone analogues kill Leishmania (Leishmania) amazonensis by inducing apoptosis and mitochondria-dependent pathway cell death.
    Granato JDT; Silva ETD; Lemos ASO; Machado PA; Midlej VDV; Antinarelli LMR; Silva Neto AFD; Souza MVN; Coimbra ES
    Chem Biol Drug Des; 2024 May; 103(5):e14535. PubMed ID: 38772877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective effects of Euterpe oleracea (açai) on Leishmania (Leishmania) amazonensis and Leishmania infantum.
    Da Silva BJM; Souza-Monteiro JR; Rogez H; Crespo-López ME; Do Nascimento JLM; Silva EO
    Biomed Pharmacother; 2018 Jan; 97():1613-1621. PubMed ID: 29793323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Aminoquinoline Derivatives as Potential Antileishmanial Agents.
    Antinarelli LM; Dias RM; Souza IO; Lima WP; Gameiro J; da Silva AD; Coimbra ES
    Chem Biol Drug Des; 2015 Oct; 86(4):704-14. PubMed ID: 25682728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antileishmanial activity of a 4-hydrazinoquinoline derivative: Induction of autophagy and apoptosis-related processes and effectiveness in experimental cutaneous leishmaniasis.
    Antinarelli LMR; de Oliveira Souza I; Zabala Capriles PV; Gameiro J; Britta EA; Nakamura CV; Lima WP; da Silva AD; Coimbra ES
    Exp Parasitol; 2018 Dec; 195():78-86. PubMed ID: 30385267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antileishmanial activity of the estrogen receptor modulator raloxifene.
    Reimão JQ; Miguel DC; Taniwaki NN; Trinconi CT; Yokoyama-Yasunaka JK; Uliana SR
    PLoS Negl Trop Dis; 2014 May; 8(5):e2842. PubMed ID: 24810565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel immunoadjuvants based on cationic lipid: Preparation, characterization and activity in vivo.
    Lincopan N; Espíndola NM; Vaz AJ; da Costa MH; Faquim-Mauro E; Carmona-Ribeiro AM
    Vaccine; 2009 Sep; 27(42):5760-71. PubMed ID: 19664738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
    Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
    Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial particles from cationic lipid and polyelectrolytes.
    Melo LD; Mamizuka EM; Carmona-Ribeiro AM
    Langmuir; 2010 Jul; 26(14):12300-6. PubMed ID: 20578678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.